4//SEC Filing
Khan Gulam Amjad 4
Accession 0001209191-19-021602
CIK 0001757898other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 3:28 PM ET
Size
16.0 KB
Accession
0001209191-19-021602
Insider Transaction Report
Form 4
STERIS LtdSTE
Khan Gulam Amjad
Sr. V.P., Procedural Solutions
Transactions
- Award
Employee Stock Option (right to buy)
2019-03-28+20,536→ 20,536 totalExercise: $114.22Exp: 2028-05-31→ Ordinary Shares (20,536 underlying) - Award
Ordinary Shares
2019-03-28+15,864→ 15,864 total - Award
Employee Stock Option (right to buy)
2019-03-28+15,000→ 15,000 totalExercise: $77.07Exp: 2027-05-30→ Ordinary Shares (15,000 underlying) - Award
Employee Stock Option (right to buy)
2019-03-28+11,700→ 11,700 totalExercise: $65.05Exp: 2025-08-27→ Ordinary Shares (11,700 underlying) - Award
Employee Stock Option (right to buy)
2019-03-28+15,000→ 15,000 totalExercise: $69.72Exp: 2026-06-01→ Ordinary Shares (15,000 underlying)
Footnotes (6)
- [F1]All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022.
- [F2]Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
- [F3]This option become exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 11,700 STERIS ordinary shares for $65.05 per share, subject to the same terms and conditions as the original Old STERIS stock option.
- [F4]This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option.
- [F5]This option becomes exercisable as follows: 3,750 on May 30, 2018;3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option.
- [F6]This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 20,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option.
Documents
Issuer
STERIS Ltd
CIK 0001757898
Entity typeother
Related Parties
1- filerCIK 0001651656
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 3:28 PM ET
- Size
- 16.0 KB